CVS Health Statistics
Total Valuation
CVS Health has a market cap or net worth of GBP 65.39 billion. The enterprise value is 121.08 billion.
Market Cap | 65.39B |
Enterprise Value | 121.08B |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025.
Earnings Date | May 1, 2025 |
Ex-Dividend Date | Apr 22, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -2.17% |
Shares Change (QoQ) | +0.16% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 1.26B |
Valuation Ratios
The trailing PE ratio is 17.74.
PE Ratio | 17.74 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.02, with an EV/FCF ratio of 23.96.
EV / Earnings | 32.85 |
EV / Sales | 0.42 |
EV / EBITDA | 10.02 |
EV / EBIT | 19.55 |
EV / FCF | 23.96 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.09.
Current Ratio | 0.81 |
Quick Ratio | 0.56 |
Debt / Equity | 1.09 |
Debt / EBITDA | 5.30 |
Debt / FCF | 13.11 |
Interest Coverage | 2.71 |
Financial Efficiency
Return on equity (ROE) is 6.02% and return on invested capital (ROIC) is 3.19%.
Return on Equity (ROE) | 6.02% |
Return on Assets (ROA) | 1.99% |
Return on Invested Capital (ROIC) | 3.19% |
Return on Capital Employed (ROCE) | 4.76% |
Revenue Per Employee | 1.14M |
Profits Per Employee | 14,202 |
Employee Count | 300,000 |
Asset Turnover | 1.47 |
Inventory Turnover | 17.79 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.34% in the last 52 weeks. The beta is 0.53, so CVS Health's price volatility has been lower than the market average.
Beta (5Y) | 0.53 |
52-Week Price Change | -14.34% |
50-Day Moving Average | 61.90 |
200-Day Moving Average | 58.20 |
Relative Strength Index (RSI) | 56.51 |
Average Volume (20 Days) | 5,964 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1.78 |
Income Statement
In the last 12 months, CVS Health had revenue of GBP 296.07 billion and earned 3.69 billion in profits. Earnings per share was 2.92.
Revenue | 296.07B |
Gross Profit | 39.34B |
Operating Income | 6.41B |
Pretax Income | 4.91B |
Net Income | 3.69B |
EBITDA | 10.08B |
EBIT | 6.41B |
Earnings Per Share (EPS) | 2.92 |
Balance Sheet
The company has 8.78 billion in cash and 66.23 billion in debt, giving a net cash position of -57.45 billion.
Cash & Cash Equivalents | 8.78B |
Total Debt | 66.23B |
Net Cash | -57.45B |
Net Cash Per Share | n/a |
Equity (Book Value) | 60.49B |
Book Value Per Share | 47.90 |
Working Capital | -12.75B |
Cash Flow
In the last 12 months, operating cash flow was 7.27 billion and capital expenditures -2.22 billion, giving a free cash flow of 5.05 billion.
Operating Cash Flow | 7.27B |
Capital Expenditures | -2.22B |
Free Cash Flow | 5.05B |
FCF Per Share | n/a |
Margins
Gross margin is 13.29%, with operating and profit margins of 2.16% and 1.24%.
Gross Margin | 13.29% |
Operating Margin | 2.16% |
Pretax Margin | 1.66% |
Profit Margin | 1.24% |
EBITDA Margin | 3.40% |
EBIT Margin | 2.16% |
FCF Margin | 1.71% |
Dividends & Yields
This stock pays an annual dividend of 2.10, which amounts to a dividend yield of 3.10%.
Dividend Per Share | 2.10 |
Dividend Yield | 3.10% |
Dividend Growth (YoY) | 6.15% |
Years of Dividend Growth | 3 |
Payout Ratio | 73.10% |
Buyback Yield | 2.17% |
Shareholder Yield | 5.27% |
Earnings Yield | 5.64% |
FCF Yield | 7.73% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CVS Health has an Altman Z-Score of 2.11. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.11 |
Piotroski F-Score | n/a |